Premium
Intimal hyperplasia and vascular remodeling after everolimus‐eluting and sirolimus‐eluting stent implantation in diabetic patients: The randomized diabetes and drug‐eluting stent (DiabeDES) IV intravascular ultrasound trial
Author(s) -
Antonsen Lisbeth,
Maeng Michael,
Thayssen Per,
Christiansen Evald Høj,
Hansen Knud Nørregaard,
Kaltoft Anne,
Hansen Henrik Steen,
Thuesen Leif,
Lassen Jens Flensted,
Jensen Lisette Okkels
Publication year - 2013
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.25180
Subject(s) - medicine , intravascular ultrasound , stent , everolimus , interquartile range , sirolimus , restenosis , percutaneous coronary intervention , cardiology , drug eluting stent , neointimal hyperplasia , urology , myocardial infarction
Objective To evaluate the effects of the everolimus‐eluting Xience™/Promus™ stent (EES) and the sirolimus‐eluting Cypher™ stent (SES) on intimal hyperplasia (IH) in diabetic patients. Background Patients with diabetes mellitus have increased risk of in‐stent restenosis after coronary stent implantation due to intimal hyperplasia (IH). Methods In a sub study of the Randomized Comparison of Everolimus‐Eluting and Sirolimus‐Eluting Stents in Patients Treated with Percutaneous Coronary Intervention (SORT OUT IV trial), serial intravascular ultrasound (IVUS) 10‐month follow‐up data were available in 88 patients, including 48 EES and 40 SES treated patients. IVUS endpoints included IH volume, in‐stent % volume obstruction and changes in external elastic membrane (EEM) volume. Results Compared with the SES group, IH volume was increased in the EES group [median (interquartile range): 2.8 mm 3 (0.0–12.6) vs. 0.0 mm 3 (0.0–1.1), P = 0.001]. In‐stent % volume obstruction was increased in EES compared to SES [median (interquartile range): 1.6% (0.0–8.2) vs. 0.0% (0.0–1.0), P = 0.001]. Peri‐stent external elastic membrane (EEM) volume: (post procedure vs. follow‐up EES [300 mm 3 (219–491) vs. 307 mm 3 (223–482), P = 0.73] and SES [316 mm 3 (235–399) vs. 323 mm 3 (246–404), P = 0.05]) and peri‐stent plaque volume: EES [163 mm 3 (103–273) vs. 184 mm 3 (115–291), P = 0.18] and SES [186 mm 3 (139–248) vs. 175 mm 3 (153–243), P = 0.26]) were unchanged in both groups. In the proximal reference segment a significant increase in plaque area was seen in the EES group only, without vascular remodeling. Conclusion In diabetic patients, EES stent implantation was associated with increased IH volume obstruction without involvement of vascular remodeling. © 2013 Wiley Periodicals, Inc.